Co-Diagnostics, Inc. Sales and Excise Tax Payable, Current
Co-Diagnostics, Inc. (CODX) had Sales and Excise Tax Payable, Current of $52.53 thousand as of 2020-12-31, per its 10-K filed 2022-03-24.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Taxes Payable, Current
us-gaap:SalesAndExciseTaxPayableCurrent · last filed 2022-03-24
- 2020-12-31: Sales and Excise Tax Payable, Current $52.53K.
| Period end | Sales and Excise Tax Payable, Current |
|---|---|
| 2020-12-31 | $52.53K 10-K · filed 2022-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |